Crossmark

Clinical implications and pharmacological considerations of glycemic variability in patients with type 2 diabetes mellitus

Published Online: 2024-10-14

Authors

Howsawi, Alanood A. https://orcid.org/0000-0002-1072-5107
Alem, Manal M. https://orcid.org/0000-0001-8447-792X
License Information

Text and Data Mining valid from 2024-10-14

Version of Record valid from 2024-10-14
More Information

Article History

Received: 10 April 2024

Accepted: 26 September 2024

First Online: 14 October 2024

Declarations

:

: The authors declare no competing interests.

: The research protocol (IRB-PGS-2021-05-054) was approved by the institutional review board (IRB), Deanship of Scientific Research at Imam Abdulrahman bin Faisal University (IAU), Dammam, Saudi Arabia. The study was conducted in accordance with the ethical principles in the Declaration of Helsinki (2013), the ICH Harmonized Tripartite Good Clinical Practice Guidelines, and the laws of Saudi Arabia. Data were collected from the electronic medical records of the participants by both investigators. Informed consent was waived by "Institutional Review Board at Imam Abdulrahman bin Faisal University" with application number: IRB-PGS-2021-05-054.

Document is current